Yajing Zhu | Karolinska Institutet

Close

A medical university

Search

Menu

A medical university

Publications
Public outreach and news

Articles

Article: BREAST CANCER RESEARCH AND TREATMENT. 2024;204(2):299-308

The role of serum thymidine kinase 1 activity in neoadjuvant-treated HER2-positive breast cancer: biomarker analysis from the Swedish phase II randomized PREDIX HER2 trial.

Zhu Y; Zerdes I; Matikas A; Cruz IR; Bergqvist M; Elinder E; Bosch A; Lindman H; Einbeigi Z; Andersson A; Carlsson L; Dreifaldt AC; Isaksson-Friman E; Hellstrom M; Johansson H; Wang K; Bergh JCS; Hatschek T; Foukakis T

All other publications

Thesis / dissertation: 2024

Unraveling predictive indicators for therapeutic response in HER2-positive breast cancer

Zhu, Yajing
Review: FRONTIERS IN ONCOLOGY. 2022;12:999843

Expression patterns and prognostic implications of tumor-infiltrating lymphocytes dynamics in early breast cancer patients receiving neoadjuvant therapy: A systematic review and meta-analysis.

Zhu Y; Tzoras E; Matikas A; Bergh J; Valachis A; Zerdes I; Foukakis T

News from KI

Events from KI